Q2 Results are out…
Consolidated Revenue Grew by 21.38%
Consolidated Profit is flat because Q2: Cons EBITDA Margin At 20.1% Vs 24.2% (YoY): (Employee Expense is up 100%)
US Business grew by 107% H1 FY15 To H1 FY16 . Contributed 33% of revenue .
Europe and UK formulation business degrew by 9% H1 FY15 To H1 FY16…Contributed 52% of revenue .
Australia & NZ business gre by 10% H1 FY15 To H1 FY16.
It seems , UK business hurt by UK regulatory import alert to Relnochem from Marksans India facility.
I don’t now how Company Secretory is telling it is not a worrying factor and revenues wont be affected ? Relnochen contributed 17% of revenue and Bell & Sons contribute 25% of revenue . Now it is clear that Europe business is suffering from that alert.